Executive Summary
A laryngeal carcinoma is a form of head and neck cancer that is quite frequent. In the United States, a rough estimate is that around 12,620 persons (9,940 men and 2,680 women) are likely to be diagnosed with laryngeal cancer this year. The annual incidence rates of this disease are decreasing by 2% to 3%. This can be due to a decrease in the number of persons who smoke. As per estimates, laryngeal cancer can claim the lives of around 3,770 people this year (750 women and 3,020 men).
The 5-year survival rate of laryngeal carcinoma is 61%. The glottis is where 60% of laryngeal cancer is detected, while the 5-year survival rate is 76%. Cancer can start in the subglottis on rare occasions, and the 5-year survival rate is 52%. The supraglottis estimates almost 35% of laryngeal cancer cases, and the 5-year survival rate is 46%. Hypopharyngeal cancer affects around 3,000 persons in the United States each year. The 5-year survival rate for hypopharyngeal carcinoma is 32%.
Survival Rates of laryngeal carcinoma
The 5-year survival rate or data indicates the percentage of persons who live for at least five years after being diagnosed with cancer. Laryngeal carcinoma has a 61 percent 5-year survival rate. More than half of patients (53%) have their cancer detected and treated before it has progressed beyond the larynx.
The 5- year survival rate depends on the cancer stage and its location of growth and metastasis.
Glottis: The glottis is where 60 percent of laryngeal cancer is detected. This malignancy has a 76 percent 5-year survival rate. The 5-year survival rate is approximately 83 percent if the disease is exclusively found in the larynx. The 5-year survival percentage for cancer that has progressed to nearby tissues or organs, as well as regional lymph nodes (regional cancer), is 48%. The survival rate is 42 percent when the cancer is in its most advanced stage and has spread to a distant portion of the body (distant cancer).
Sub glottis: Cancer can start in the sub glottis on rare occasions. This malignancy has a 5-year survival rate of 52 percent . The 5-year survival rate is 60% if the cancer is in the larynx. 5-year survival rate for cancer growth that is regional is 33%. The 5-year survival rate is 45 percent at this stage.
Supraglottis: The supraglottis is home to about 35% of laryngeal cancer cases. This malignancy has a 46 percent 5-year survival rate. The 5-year survival rate is 61 percent if the cancer is in the larynx. The 5-year survival rate for regional cancer is 47 percent. The survival rate for distant supraglottis carcinoma is 30% after five years.
HYPOPHARYNGEAL CANCER
Hypopharyngeal cancer affects around 3,000 persons in the United States each year. Even so, the survival rates for hypopharyngeal carcinoma vary depending on several factors, including the stage of the disease. Moreover, hypopharyngeal carcinoma has a 32 percent 5-year survival rate. People with hypopharyngeal cancer have a 59 percent 5-year survival rate if diagnosed at an early, localized stage.
The 5-year survival rate is 33% if cancer has spread to other tissues or organs, as well as regional lymph nodes. The 5-year survival rate is 21% if cancer has progressed to other body regions. Because of its location, hypopharyngeal carcinoma is frequently discovered later. Hoarseness or bloody coughing are common symptoms of laryngeal cancer, leading to an early diagnosis. Hypopharyngeal malignancies might be unnoticed for a long time.
It is also important to remember that statistics on laryngeal and hypopharyngeal cancer survival rates are mere estimates. The figures are based on annual data on the number of people diagnosed with various cancers in the United States. Experts also assess the survival data every five years. As a result, the estimate may not cent percent reflects the outcomes of improved diagnosis or therapy that has been available for less than five years. If you have any queries concerning this information, speak with your doctor or healthcare team.
